INDOAMIN Stock Overview
Engages in the manufacture, distribution, and sale of fine and specialty chemicals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Indo Amines Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹170.39 |
| 52 Week High | ₹248.40 |
| 52 Week Low | ₹106.60 |
| Beta | 0.89 |
| 11 Month Change | 3.17% |
| 3 Month Change | 4.04% |
| 1 Year Change | 50.32% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 50.32% |
Recent News & Updates
There's Reason For Concern Over Indo Amines Limited's (NSE:INDOAMIN) Massive 32% Price Jump
Sep 26
Indo Amines (NSE:INDOAMIN) Is Due To Pay A Dividend Of ₹0.50
Sep 17Recent updates
There's Reason For Concern Over Indo Amines Limited's (NSE:INDOAMIN) Massive 32% Price Jump
Sep 26Indo Amines (NSE:INDOAMIN) Is Due To Pay A Dividend Of ₹0.50
Sep 17Indo Amines (NSE:INDOAMIN) Is Paying Out A Dividend Of ₹0.50
Sep 03Indo Amines Limited (NSE:INDOAMIN) Shares Fly 30% But Investors Aren't Buying For Growth
Aug 12Indo Amines (NSE:INDOAMIN) Has Affirmed Its Dividend Of ₹0.50
Aug 11Here's Why Indo Amines (NSE:INDOAMIN) Has A Meaningful Debt Burden
Aug 07Does Indo Amines (NSE:INDOAMIN) Deserve A Spot On Your Watchlist?
Jul 17Indo Amines Limited's (NSE:INDOAMIN) Earnings Are Not Doing Enough For Some Investors
Jun 28Indo Amines Limited (NSE:INDOAMIN) Might Not Be As Mispriced As It Looks After Plunging 25%
Mar 09Does Indo Amines (NSE:INDOAMIN) Have A Healthy Balance Sheet?
Feb 18Should You Be Adding Indo Amines (NSE:INDOAMIN) To Your Watchlist Today?
Jan 31Even With A 33% Surge, Cautious Investors Are Not Rewarding Indo Amines Limited's (NSE:INDOAMIN) Performance Completely
Jan 03A Look Into Indo Amines' (NSE:INDOAMIN) Impressive Returns On Capital
Dec 07Pinning Down Indo Amines Limited's (NSE:INDOAMIN) P/E Is Difficult Right Now
Jun 14Shareholder Returns
| INDOAMIN | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -0.8% | 1.5% | 2.0% |
| 1Y | 50.3% | 12.6% | 28.6% |
Return vs Industry: INDOAMIN exceeded the Indian Chemicals industry which returned 12.6% over the past year.
Return vs Market: INDOAMIN exceeded the Indian Market which returned 28.6% over the past year.
Price Volatility
| INDOAMIN volatility | |
|---|---|
| INDOAMIN Average Weekly Movement | 8.9% |
| Chemicals Industry Average Movement | 5.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: INDOAMIN's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: INDOAMIN's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 557 | Vijay Palkar | indoaminesltd.com |
Indo Amines Limited engages in the manufacture, distribution, and sale of fine and specialty chemicals in India and internationally. The company’s fine chemicals comprise aliphatic and aromatic amines, aliphatic and aromatic nitriles, halides, alcohols, cycloalkanols, cycloalkanones, acids and esters, advanced intermediates, amine hydrochlorides, ethanol amines, and other products. Its specialty chemicals include fatty acids, amides, amines, di-amines, tertiary amines, polyamines, amine ethoxylates, and ammonium quats.
Indo Amines Limited Fundamentals Summary
| INDOAMIN fundamental statistics | |
|---|---|
| Market cap | ₹12.08b |
| Earnings (TTM) | ₹516.10m |
| Revenue (TTM) | ₹9.81b |
23.4x
P/E Ratio1.2x
P/S RatioIs INDOAMIN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INDOAMIN income statement (TTM) | |
|---|---|
| Revenue | ₹9.81b |
| Cost of Revenue | ₹6.72b |
| Gross Profit | ₹3.09b |
| Other Expenses | ₹2.58b |
| Earnings | ₹516.10m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.30 |
| Gross Margin | 31.51% |
| Net Profit Margin | 5.26% |
| Debt/Equity Ratio | 91.1% |
How did INDOAMIN perform over the long term?
See historical performance and comparison